Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30011690HIVENSG00000139144.11protein_codingPIK3C2GNoNo5288B7ZLY6
F5H369
O75747
TVIS30006093HIVENSG00000139144.11protein_codingPIK3C2GNoNo5288B7ZLY6
F5H369
O75747
TVIS30077710HIVENSG00000139144.11protein_codingPIK3C2GNoNo5288B7ZLY6
F5H369
O75747
TVIS30079467HIVENSG00000139144.11protein_codingPIK3C2GNoNo5288B7ZLY6
F5H369
O75747
TVIS30081808HIVENSG00000139144.11protein_codingPIK3C2GNoNo5288B7ZLY6
F5H369
O75747
TVIS20011080HPVENSG00000139144.11protein_codingPIK3C2GNoNo5288B7ZLY6
F5H369
O75747
TVIS20010851HPVENSG00000139144.11protein_codingPIK3C2GNoNo5288B7ZLY6
F5H369
O75747
TVIS20031269HPVENSG00000139144.11protein_codingPIK3C2GNoNo5288B7ZLY6
F5H369
O75747
TVIS20050639HPVENSG00000139144.11protein_codingPIK3C2GNoNo5288B7ZLY6
F5H369
O75747
TVIS20050574HPVENSG00000139144.11protein_codingPIK3C2GNoNo5288B7ZLY6
F5H369
O75747
TCGA Plot Options
Drug Information
GenePIK3C2G
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0009515
UniProt IDO75747
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830